Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C. Talleur, Stephen Gottschalk, Amr Qudeimat et al.|Blood Advances|2022Cited by 62
Integrome signatures of lentiviral gene therapy for SCID-X1 patientsKoon‐Kiu Yan, Jiyang Yu, Yogesh Dhungana et al.|Science Advances|2023Cited by 9
Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center ExperienceAimee C. Talleur, Stephen Gottschalk, Renee Madden et al.|Blood|2020Cited by 3